Aberrantly Expressed Timeless Regulates Cell Proliferation and Cisplatin Efficacy in Cervical Cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Timeless (TIM) is a regulator of the molecular clock and implicated in mammalian cancer development.
• Cervical cancer progression involves dysregulated cell proliferation and chemoresistance.
• Understanding Timeless's role in cervical cancer is crucial for therapeutic strategies.

Purpose of the Study:

• To investigate the impact of Timeless on cervical cancer cell proliferation.
• To determine the effect of Timeless on cisplatin sensitivity in cervical cancer.
• To elucidate the molecular mechanisms underlying Timeless's function in cervical cancer.

Main Methods:

• Timeless expression analysis using bioinformatics, immunohistochemistry, and qPCR.
• Chromatin immunoprecipitation and reporter gene assays to identify transcriptional factors.
• In vitro and in vivo experiments assessing cell proliferation, apoptosis, senescence, and DNA damage.
• Western blot analysis of the ATR/CHK1 DNA repair pathway.

Main Results:

• Timeless is aberrantly expressed in approximately 52.5% of cervical cancer tissues.
• E2F1 and E2F4 transcription factors contribute to Timeless upregulation.
• Timeless depletion inhibited cell proliferation and enhanced cisplatin sensitivity in vitro and in vivo.
• Timeless knockdown induced apoptosis and senescence, causing DNA damage and impairing ATR/CHK1 pathway activation.

Conclusions:

• Timeless is overexpressed in cervical cancer and promotes proliferation while reducing cisplatin sensitivity.
• Timeless acts as a key regulator of DNA damage response and repair pathways.
• Targeting Timeless presents a promising strategy for developing novel cisplatin sensitizers in cervical cancer therapy.